 |
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2025, vol. 31, issue1
Subject Area: Medicine
-
DOI: 10.5272/jimab.2025311.6095
Published online: 31 March 2025
Original article
J of IMAB. 2025 Jan-Mar;31(1):6095-6102
PLACENTA ACCRETA – RISK FACTORS, SURGICAL AND CLINICAL OUTCOME
Mariana Tsankova1, 2
, Sergei Slavov1, 2
, Ivan Kostov1, 2,
1) University Hospital of Obstetrics and Gynecology "Maichin Dom", Sofia, Bulgaria.
2) Department of Obstetrics and Gynecology, Medical University, Sofia, Bulgaria.
ABSTRACT:
Placenta accreta is a spectrum of antenatal diagnostic markers, surgical complications and life-threatening diagnoses.
Objective: To evaluate the risk factors, the surgical complications and the clinical peripartal outcomes in the placenta accreta spectrum.
Materials and methods: The study represents an 11-year prospective follow-up of 58 cases of placenta accreta, sonografically diagnosed, clinically managed and pathohystologically confirmed. The rate of placenta accreta was 34,5%, placenta percreta - 56,9% and partial placenta accreta 8.6%. In The main risk factors were a previous caesarean section and placenta previa. Additional risk factors were advanced maternal age, multiparity, IVF procedures, previous uterine curettage, anterior placenta. The control group consisted of 135 cases with normal placenta.
Results: We found an increaseed rate of caesarean births and a corresponding increase in placenta previa rate. The peripartal hysterectomy rate was 91%. Surgical complications were mostly uterovesical lesions and excessive haemorrhage. Blood loos in the groups with an emergency hysterectomy and ralaparotomy was in the range of 3510 ml – 6500 ml, compared to 3420 ml in planed delivery with caesarean hysterectomy due to placenta accreta. More resuscitation measures and longer hospital stay was observed in cases with a placenta accreta spectrum. The neonatal clinical outcome was good according to fetal weight and Apgar score at delivery.
Conclusion: Our results revealed good clinical confirmation in 90% of cases by expert ultrasonographers, followed by clinical and histopathological confirmation in all cases. This diagnosis and its surgical treatment will continue to be a professional challenge.
Keywords: Placenta accreta, placenta previa, Cesarean section, peripartal hysterectomy,
- Download FULL TEXT /PDF 1587 KB/
Please cite this article as: Tsankova M, Slavov S, Kostov I. Placenta accreta – risk factors, surgical and clinical outcome. J of IMAB. 2025 Jan-Mar;31(1):6095-6102. [Crossref - 10.5272/jimab.2025311.6095]
Correspondence to: Sergei Svetoslavov Slavov, University Hospital of Obstetrics and Gynecology "Maichin Dom", Sofia; Department of Obstetrics and Gynecology, Medical University, Sofia; 15, Iv. Ev. Geshov Blvd., 1431, Sofia, Bulgaria; E-mail: sergeislavov66@gmail.com
REFERENCES:
1. Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018 Mar;140(3):274-280. [PubMed]
2. Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. BJOG. 2019 Jan;126(1):e1-e48. [PubMed ]
3. ACOG; Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol. 2018 Dec;132(6):e259-e275. [PubMed]
4. Arakaza A, Zou L, Zhu J. Placenta accrete spectrum; Diagnosis challenges and controversies in current obstetrics: A review. Int J Womens Helth. 2023 Apr 20;15:635-654. [PubMed]
5. Kennedy A, Griffith A, Emersson B, Woodword P. Pitfalls in sonographic evaluation of placenta accreta spectrum. WFUMB Ultrasound Open. 2023 Dec;1(2):100016 [Crossref]
6. Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016 Mar;47(3):271-5. [PubMed]
7. Cesarean section rates continue to rise, amid growing inequalities in access. WHO. 16 June 2021. [Internet]
8. Kayem G, Seco A, Vendittelli F, Grenn Hebert C, Dupont C, Branger B, et al. Risk factors for placenta accreta spectrum disorders in women with any prior caesarean and placenta previa or low lying: a prospective population- based study. Sci Rep. 2024 Mar 19;14(1):6564. [PubMed]
9. Emerson BD, Gilner JB, Zuckerwise LC. Placenta accreta spectrum. Obstet Gynecol. 2023 Jun 1;142(1):31-50. [PubMed]
10. Jauniaux E, Jurkovic D, Hussein AM, Graham JB. New insights into the etiopathology of placenta accreta spectrum. Am J Obstet Gynecol. 2022 Sep;227(3):384-391 [PubMed]
11. Jauniaux E, Chantraine F, Silver RM, Langhoff-Ross J. FIGO consensus guidelines on placenta acreta spectrum disorders: Epidemiology. Int J Gynecol Obstet. 2018 Mar;140(3):265-273. [PubMed]
12. Morlando M, Collins S. Placenta accreta spectrum disorders challenges, risks and management strategies. Int J Womens Health. 2020 Nov 10;12:1033-1045. [PubMed]
13. Vintzieos AM, Ananth CV, Smulian JC. Using ultrasound in the clinical management of placental implantation anomalies. Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S70-7. [PubMed]
14. Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012; 7(12):e52893. [PubMed]
15. Kaser DJ, Melamed A, Bormann CL, Myers DE, Missmer SA, Walsh BW, et al. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil Steril. 2015 May;103(5):1176-84. [PubMed]
16. Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductve technology and the risk of pregnancy-related complicatons and adverse pregnancy outcomes in singleton pregnancies: A meta-analysis of cohort studies. Fertil Steril. 2016 Feb;105(1):73-85. [PubMed]
17. Jauniaux E , Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet and Gynecol. 2019 Sep;221(3):208-218. [PubMed]
18. Zuckerwise LC, Craig AM, Newton JM, Zhan S, Bennett KA, Crispens MA. Outcomes following clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2020 Feb;222(2):179.e1-179.e9. [PubMed]
19. Cojocaru L, Lankford A, Galey J, Bharadwaj S, Kpdali B, Kennedy K, et al. Surgical advances in the management of placenta accreta spectrum: establishing new expectations for operative blood loss. J Matern Fetal Neonatal Med. 2022 Dec;35(23);4496-4505. [PubMed]
20. Dannheim K, Shainker SA, Hecht JL. Hysterectomy for placenta accreta; methods for gross and microscopic pathology examinaton. ArchGynecolObstet. 2016 May;293(5):951-8. [PubMed] .
Received: 21 November 2024
Published online: 31 March 2025